KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesChange in InventoryDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Change in Inventory (2018 - 2025)

Historic Change in Inventory for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $6.0 million.

  • BioNTech SE's Change in Inventory fell 8532.72% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.6 million, marking a year-over-year decrease of 2745.0%. This contributed to the annual value of $79.6 million for FY2024, which is 965.64% down from last year.
  • BioNTech SE's Change in Inventory amounted to $6.0 million in Q3 2025, which was down 8532.72% from $25.8 million recorded in Q2 2025.
  • BioNTech SE's 5-year Change in Inventory high stood at $97.7 million for Q2 2022, and its period low was -$388.3 million during Q3 2021.
  • Over the past 5 years, BioNTech SE's median Change in Inventory value was $16.6 million (recorded in 2023), while the average stood at -$20.8 million.
  • As far as peak fluctuations go, BioNTech SE's Change in Inventory tumbled by 21232975321.51% in 2021, and later skyrocketed by 4854511532.04% in 2022.
  • BioNTech SE's Change in Inventory (Quarter) stood at -$124.8 million in 2021, then decreased by 18.37% to -$147.7 million in 2022, then skyrocketed by 142.24% to $62.4 million in 2023, then crashed by 65.92% to $21.3 million in 2024, then plummeted by 71.96% to $6.0 million in 2025.
  • Its Change in Inventory was $6.0 million in Q3 2025, compared to $25.8 million in Q2 2025 and $35.6 million in Q1 2025.